Article Contents ::
- 1 Details About Generic Salt :: Cosyntro
- 2 Main Medicine Class:: Adrenal cortical steroid
- 3 (koe-sin-TROE-pin) Cortrosyn Class: Adrenal cortical steroid
- 4 Drugs Class ::
- 5 Disclaimer ::
- 6 The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.
Details About Generic Salt :: Cosyntro
Main Medicine Class:: Adrenal cortical steroid
(koe-sin-TROE-pin)
Cortrosyn
Class: Adrenal cortical steroid
Drugs Class ::
Action Exhibits full corticosteroidogenic activity of natural ACTH, stimulating adrenal cortex to produce and secrete adrenocortical hormones.
Indications for Drugs ::
Indications Diagnostic testing of adrenal function.
Drug Dose ::
Route/Dosage
ADULTS: IM/IV (direct injection) 0.25–0.75 mg. IV infusion 0.25 mg in D5W or 0.9% saline administered at 0.04 mg/hr over 6 hr. CHILDREN £ 2 YR: IM/IV 0.125 mg often will be sufficient.
Contraindication ::
Contraindications Standard considerations.
Drug Precautions ::
Precautions
Pregnancy: Category C. Lactation: Undetermined. Hypersensitivity: Exhibits slight immunologic activity but is less likely to cause reactions than natural ACTH.
PATIENT CARE CONSIDERATIONS |
|
Drug Side Effects ::
Adverse Reactions
OTHER: Rare hypersensitivity.
Drug Mode of Action ::
Action Exhibits full corticosteroidogenic activity of natural ACTH, stimulating adrenal cortex to produce and secrete adrenocortical hormones.
Drug Interactions ::
Interactions
Anticholinesterases: May antagonize anticholinesterase effects in myasthenia gravis. Barbiturates: May decrease pharmacologic effect of cosyntropin. Hydantoins: May increase clearance and decrease therapeutic efficacy of cosyntropin.
Drug Assesment ::
Assessment/Interventions
- Obtain patient history, including drug history and any known allergies. Note hypersensitivity to natural corticotropin.
- Measure plasma cortisol concentrations prior to and 30–60 min after administration. Collect blood sample of 6–7 ml in heparinized tube.
- Alternatively, measure urinary steroids before and after IV infusion.
Drug Storage/Management ::
Administration/Storage
- Before administration, be prepared to treat possible acute hypersensitivity reaction.
- Administer by IM route, direct IV injection or IV infusion.
- Reconstitute 0.25 mg vial with 1 ml of 0.9% Sodium Chloride for Injection.
- Administer reconstituted drug via IM route or by direct IV injection over 2 min or further dilute in D5W or normal saline and infuse over 4–8 hr.
- Do not allow cosyntropin to mix with blood or plasma infusions.
- Reconstituted preparations should not be retained.
Drug Notes ::
Patient/Family Education
- Explain purpose of the test.
- Emphasize importance of lab tests.
- Instruct patients taking corticosteroids or aldosterone to omit doses on day of test.